Astrazeneca Kft. secures contract for Pharmaceutical Products - Successive Delivery of Tremelimumab for the National Oncology Institute of Maria Sklodowska -Curie - the National Research Institute of the Branch in Gliwice

Poland, July 8 -- Poland based Astrazeneca Kft. has secured contract from Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy Oddzial w Gliwicach for Pharmaceutical Products - Successive Delivery of Tremelimumab for the National Oncology Institute of Maria Sklodowska -Curie - the National Research Institute of the Branch in Gliwice. The value of the contract is worth 25201350 PLN.

Published by HT Digital Content Services with permission from Pivotal Sources....